Group 1 - The National Medical Products Administration plans to complete the review and approval of clinical trial applications for eligible innovative drugs within 30 working days [1] - A new round of insurance premium rate reductions has begun, with the joint venture insurance company Tongfang Global Life launching two new dividend insurance products, reducing the premium rate from the current market cap of 2% by 50 basis points to 1.5% [2] - The Ministry of Finance announced that Dalian and Hubei provinces will implement a tax refund policy for overseas travelers' shopping starting from July 1, 2025 [3] Group 2 - Goldman Sachs remains optimistic about global funds returning to China, favoring stocks of ten major companies including Tencent, Alibaba, Xiaomi, BYD, Meituan, NetEase, Midea, Hansoh Pharmaceutical, Trip.com, and Anta [4] - Beiken Energy is planning a change of control, while Yuanlong Yatu has seen a significant stock increase without any violations of information disclosure [5] - Lakala is planning to list on the Hong Kong Stock Exchange and accelerate the application of digital currency in cross-border scenarios [5] - Jin Chengzi reported that revenue from 3D printing equipment will account for less than 2% of the company's total revenue in 2024 [5] - Tongyuan Petroleum stated that the Israel-Palestine conflict has not affected its business operations [5] - Weir Group's stock name will change to Haowei Group starting June 20 [5] - Shandong Molong reported no significant changes in recent production and operational conditions [5]
6月16日晚间新闻精选
news flash·2025-06-16 13:52